Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LEVETIRACETAM INJECTION USP - Health Canada Drug Approval Details

Approvals/Health Canada/LEVETIRACETAM INJECTION USP

Authorized

STANDARD

LEVETIRACETAM INJECTION USP

Sterimax Inc🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: b8230b085782da93
Company: Sterimax Inc
Type: Standard

Approval Details

Approval Id: b8230b085782da93
Drug Approval Canada Name: LEVETIRACETAM INJECTION USP
Product Name: LEVETIRACETAM INJECTION USP
Status: Marketed
Status Date: 2022-08-05
Original Market Date: 2022-08-05
Din: 02527375
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 28:12.92
Atc Original: N03AX14 LEVETIRACETAM
Atc Name: n 03 ax 14
Aig Number: 0148843005
Company Name: Sterimax Inc
Company Address: 2770 Portland Drive, Oakville, Ontario, Canada, L6H 6R4

Active Ingredients

LEVETIRACETAM

100 MG / ML

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b8230b085782da93

Type

Standard

Back to Health Canada Approvals